Search research articles
Contact Us
Filters
Showing results (521-530 of 831) with videos related to
Page
of 84
Sort By:
Neuro-Oncology
|
August 23, 2019
Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression
Norbert Galldiks, Martin Kocher, Garry Ceccon, et al.
Acta Neuropathologica
|
September 2, 2019
FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomas
Frank Brand, Alisa Förster, Anne Christians, et al.
Scientific Data
|
August 8, 2018
A tissue-based draft map of the murine MHC class I immunopeptidome
Heiko Schuster, Wenguang Shao, Tobias Weiss, et al.
Molecular Imaging
|
November 20, 2020
Molecular MR-Imaging for Noninvasive Quantification of the Anti-Inflammatory Effect of Targeting Interleukin-1β in a Mouse Model of Aortic Aneurysm
Julia Brangsch, Carolin Reimann, Jan Ole Kaufmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 29, 2022
Multifunctional mRNA-Based CAR T Cells Display Promising Antitumor Activity Against Glioblastoma
Hanna Meister, Thomas Look, Patrick Roth, et al.
Clinical & Experimental Metastasis
|
August 25, 2014
αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer
Anna Sophie Berghoff, Astrid Kerstin Kovanda, Thomas Melchardt, et al.
BMC Cancer
|
January 15, 2024
A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol
Maximilian Mastall, Patrick Roth, Andrea Bink, et al.
Neuro-Oncology
|
February 4, 2021
Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group
Norbert Galldiks, Maximilian Niyazi, Anca L Grosu, et al.
International Journal of Cancer
|
March 12, 2014
Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy
Michael Weller, Kerstin Kaulich, Bettina Hentschel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2006
Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03
Ulrich Herrlinger, Johannes Rieger, Dorothee Koch, et al.
Page
of 84
Search research articles
Search
Showing results (521-530 of 831) with videos related to
Sort By:
Page
of 84
Neuro-Oncology
|
August 23, 2019
Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression
Norbert Galldiks, Martin Kocher, Garry Ceccon, et al.
Acta Neuropathologica
|
September 2, 2019
FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomas
Frank Brand, Alisa Förster, Anne Christians, et al.
Scientific Data
|
August 8, 2018
A tissue-based draft map of the murine MHC class I immunopeptidome
Heiko Schuster, Wenguang Shao, Tobias Weiss, et al.
Molecular Imaging
|
November 20, 2020
Molecular MR-Imaging for Noninvasive Quantification of the Anti-Inflammatory Effect of Targeting Interleukin-1β in a Mouse Model of Aortic Aneurysm
Julia Brangsch, Carolin Reimann, Jan Ole Kaufmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 29, 2022
Multifunctional mRNA-Based CAR T Cells Display Promising Antitumor Activity Against Glioblastoma
Hanna Meister, Thomas Look, Patrick Roth, et al.
Clinical & Experimental Metastasis
|
August 25, 2014
αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer
Anna Sophie Berghoff, Astrid Kerstin Kovanda, Thomas Melchardt, et al.
BMC Cancer
|
January 15, 2024
A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol
Maximilian Mastall, Patrick Roth, Andrea Bink, et al.
Neuro-Oncology
|
February 4, 2021
Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group
Norbert Galldiks, Maximilian Niyazi, Anca L Grosu, et al.
International Journal of Cancer
|
March 12, 2014
Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy
Michael Weller, Kerstin Kaulich, Bettina Hentschel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2006
Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03
Ulrich Herrlinger, Johannes Rieger, Dorothee Koch, et al.
Page
of 84